Starcoin Group Company Description

Starcoin Group Limited, an investment holding company, engages in the trading of beauty products in the People’s Republic of China and Hong Kong.

It operates in two segments, Trading of Beauty Products, and Research and Development. The company is also involved in the research, development, and commercialization of oral insulin products; and the provision of genetic testing services, as well as securities investment.

In addition, it offers healthcare management and bio-industrial products distribution services. The company was formerly known as Innovative Pharmaceutical Biotech Limited and changed its name to Starcoin Group Limited in August 2025.

Starcoin Group Limited was incorporated in 2000 and is based in Central, Hong Kong.

Starcoin Group Limited

Country	Bermuda
Founded	2000
Industry	Specialty Retail
Sector	Consumer Discretionary
Employees	29
CEO	Ming Wu

Contact Details

Address: 21/F, Henley Building Central Hong Kong
Phone	852 2598 6638
Website	starcoingroup.com

Stock Details

Ticker Symbol	0399
Exchange	Hong Kong Stock Exchange
Fiscal Year	April - March
Reporting Currency	HKD
ISIN Number	BMG4783W1073
SIC Code	2835

Key Executives

Name	Position
Dr. Ming Wu	Chief Executive Officer and Executive Director
Dr. Yung Yeung	Executive Chairman
Rong Tang	Executive Director
Yuan Xing Gao	Executive Director
Shujuan Qi	Executive Director
Dr. Yumin Mao Ph.D.	Honorary Chairman and Chief Scientific Adviser
Hon Yin Poon	Financial Controller and Company Secretary
Dr. Peilun Li	Chief Technology Officer
Qi Dong	Sales Head of the Group
Dr. Wei Ping Yu	Joint Chairman to the Department of Innovation and Strategic Development and Advisor